Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 243 Jul 27 – Oct 24, 2026
- Disclosed funding
- $6.3B 177 disclosed amounts
- Median round
- $14.2M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| TB Developing nerve-targeted imaging technologies for surgery. | Undisclosed | Series A | Healthtech, Biotech | United States | Investors | |
| Q QureightCompany profile End-to-end imaging company for clinical trials with a focus on lung and heart disease. End-to-end imaging company for clinical trials with a focus on lung and heart disease. | $20M | Series B | Healthtech | United Kingdom | Investors | |
| A AurenarCompany profile Developer of a non-invasive, single-use neuromodulation platform to reduce life-threatening complications in ICU patients. Developer of a non-invasive, single-use neuromodulation platform to reduce life-threatening complications in ICU patients. | $5.7M | Seed | Healthtech | United States | Investors | |
| PA AI-powered medical billing company for surgeons in private practice. | $10M | Series A | Healthtech | United States | Investors | |
| TS Throne ScienceCompany profile A smart toilet sensor that tracks gut health, hydration, and urinary function automatically with every flush. A smart toilet sensor that tracks gut health, hydration, and urinary function automatically with every flush. | $10M | Series A | Healthtech | United States | Investors | |
| H Healia is a healthcare benefits platform built for dual-income families. | $14M | Series A | Healthtech, Fintech | United States | Investors | |
| CB CORE BiomedicineCompany profile Developing the next generation of precision medicines by going beyond genomics. Developing the next generation of precision medicines by going beyond genomics. | $21M | Series A | Healthtech, Biotech | United States | Investors | |
| TP Torrey Pines MedicineCompany profile Develops ultra-long-acting peptide therapeutics for obesity, diabetes, and metabolic diseases Develops ultra-long-acting peptide therapeutics for obesity, diabetes, and metabolic diseases | Undisclosed | Pre-SeedPre-seed | Healthtech, Biotech | China | Investors | |
| EI Develops AI-driven wireless technologies for brain health. | $26M | Series B | Healthtech | United States | Investors | |
| VD Vivid DxCompany profile Rapid infectious disease testing helping hospitals identify pathogens and guide antibiotic decisions Rapid infectious disease testing helping hospitals identify pathogens and guide antibiotic decisions | $15M | Seed | Healthtech | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jul 27, 2026
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
6rounds1led - 2Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
6rounds2led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
5rounds0led - 4Y Combinator (YC)
Vitalize, Angle Health, Metriport
5rounds0led - 5European Investment Bank
HighLife, MMI, Tensive
5rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.